ALAD anticorps (N-Term)
Aperçu rapide pour ALAD anticorps (N-Term) (ABIN927973)
Antigène
Voir toutes ALAD AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- ALAD antibody was raised in rabbit using the N terminal of ALAD as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
ALAD Blocking Peptide, (ABIN5612000), is also available for use as a blocking control in assays to test for specificity of this ALAD antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ALAD (Aminolevulinate Dehydratase (ALAD))
-
Autre désignation
- ALAD
-
Sujet
- The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway, zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria. Synonyms: Polyclonal ALAD antibody, Anti-ALAD antibody, aminolevulinate, delta-, dehydratase antibody, ALADH antibody, MGC5057 antibody, PBGS antibody.
Antigène
-